Betekenis van:
moiety

moiety
Zelfstandig naamwoord
    • one of two basic subdivisions of a tribe

    Hyperoniemen

    moiety
    Zelfstandig naamwoord
      • one of two (approximately) equal parts

      Synoniemen

      Hyperoniemen


      Voorbeeldzinnen

      1. clofentezin (sum of all compounds containing the 2-Chlorbenzoyl-moiety expr. as Clofentezin)
      2. Amitraz Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz Bovine
      3. Vinclozolin (sum of Vinclozolin and all metabolites cont. the 3,5-dichloraniniline moiety, expr. as Vinclozolin)
      4. Prochloraz (sum of Prochloraz + its metabolites cont. the 2,4,6-Trichlorophenol moiety expressed as Prochloraz)
      5. Flufenacet (sum of all compounds containing the N fluorophenyl-N-isopropyl moiety expressed as flufenacet equivalent)
      6. Flufenacet (Sum of all compounds containing the N fluorophenyl-N-isopropyl moiety expressed as flufenacet)
      7. Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz
      8. Prochloraz (sum of prochloraz and its metabolites containing the 2,4,6-Trichlorophenol moiety expressed as prochloraz) — code number 0213070:
      9. Flufenacet (sum of all compounds containing the N fluorophenyl-N-isopropyl moiety expressed as flufenacet equivalent) Flumioxazine
      10. Prochloraz (sum of prochloraz and its metabolites containing the 2,4,6-Trichlorophenol moiety expressed as prochloraz) — code number 0500060:
      11. A reducing disaccharide that consists of one glucose and one fructose moiety linked by an alpha-1,6-glycosidic bond.
      12. the risk to aquatic organisms from metabolites containing the benzyl moiety, the risk of biomagnification in aquatic food chains.
      13. Prochloraz (sum of prochloraz and its metabolites containing the 2,4,6-Trichlorophenol moiety expressed as prochloraz) — code number 0500020:
      14. replacement of a chemical active substance by a different salt/ester complex/derivative, with the same therapeutic moiety, where the efficacy/safety characteristics are not significantly different;
      15. The polyglycerol moiety is predominantly di-, tri- and tetraglycerol and contains not more than 10 % of polyglycerols equal to or higher than heptaglycerol